Valuation Financière de Tubize S.A.

Equities

Real-time Euronext Bruxelles Other stock markets 07:05:49 2024-09-20 am EDT			5-day change	1st Jan Change
131.00 ^EUR	+0.61%		-0.76%	+82.71%

Jul. 25	Financière de Tubize SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
Mar. 27	Financière de Tubize SA Announces Board Resignations	CI

Fiscal Period: December	2018	2019	2020	2021	2022	2023
Capitalization ¹	2,704	2,827	3,677	4,019	3,151	3,192
Change	-	4.53%	30.08%	9.32%	-21.59%	1.27%
Enterprise Value (EV) ¹	2,846	2,913	3,709	4,024	3,198	3,270
Change	-	2.35%	27.34%	8.47%	-20.51%	2.25%
P/E ratio	9.48x	9.96x	14.1x	10.6x	37x	36.2x
PBR	1.16x	1.06x	1.32x	1.24x	1.8x	1.78x
PEG	-	-22.87x	-1.73x	0.2x	-0.5x	10.34x
Capitalization / Revenue	-	-	-	-	386,638,687,032x	-
EV / Revenue	-	-	-	-	392,371,878,420x	-
EV / EBITDA	-	-	-	-	-	-
EV / EBIT	-3,450x	-2,934x	-1,649x	-2,965x	-1,755x	-1,573x
EV / FCF	-1,487x	-1,888x	-2,405x	-8,116x	-1,352x	-1,173x
FCF Yield	-0.07%	-0.05%	-0.04%	-0.01%	-0.07%	-0.09%
Dividend per Share ²	0.56	0.62	0.68	0.75	0.86	0.97
Rate of return	0.92%	0.98%	0.82%	0.83%	1.21%	1.35%
EPS ²	6.401	6.374	5.853	8.539	1.913	1.98
Distribution rate	8.75%	9.73%	11.6%	8.78%	44.9%	49%
Net sales	-	-	-	-	0.008151	-
EBITDA	-	-	-	-	-	-
EBIT ¹	-0.825	-0.993	-2.249	-1.357	-1.823	-2.079
Net income ¹	285.2	283.7	260.5	380.1	85.17	88.15
Net Debt ¹	142	86.47	32.64	4.141	46.73	78.63
Reference price ²	60.70	63.50	82.60	90.30	70.80	71.70
Nbr of stocks (in thousands)	44,549	44,513	44,513	44,513	44,513	44,513
Announcement Date	2/28/19	2/20/20	2/27/21	2/26/22	3/18/23	3/15/24

¹EUR in Million²EUR

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
ELI LILLY AND COMPANY	59x	18.28x	44.45x	+0.57%	824B
NOVO NORDISK A/S	39.55x	13.77x	28.05x	+1.27%	595B
JOHNSON & JOHNSON	21.1x	4.56x	12.91x	+2.84%	397B
ABBVIE INC.	37.68x	7.14x	15.43x	+3.22%	342B
MERCK & CO., INC.	15.63x	4.97x	11.38x	+2.62%	297B
ROCHE HOLDING AG	16.05x	3.79x	9.8x	+3.68%	254B
ASTRAZENECA PLC	28.29x	5.09x	15.23x	+1.96%	245B
NOVARTIS AG	21.55x	4.96x	12.57x	+3.26%	235B
AMGEN INC.	51.75x	6.95x	12.17x	+2.73%	181B
Average	32.29x	7.72x	18.00x	+2.46%	374.33B
Weighted average by Cap.	36.64x	9.98x	23.29x	+2.05%